NLRP3 Inflammasome Targeting Offers a Novel Therapeutic Paradigm for Sepsis-Induced Myocardial Injury

NLRP3 Inflammasome Targeting Offers a Novel Therapeutic Paradigm for Sepsis-Induced Myocardial Injury

Yuzi Jin,1,* Joshua S Fleishman,2,* Yudong Ma,3 Xiaoqing Jing,4 Qin Guo,1 Weiguang Shang,1 Hongquan Wang5 1Department of Pediatrics, Central Hospital Affiliated to Shenyang Medical College, Shenyang, 110020, People’s Republic of China; 2Department of Pharmaceutical Sciences, College...

Full description

Bibliographic Details
Main Authors: Jin Y, Fleishman JS, Ma Y, Jing X, Guo Q, Shang W, Wang H
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Drug Design, Development and Therapy
Subjects:
sepsis
sepsis-induced myocardial injury
nlrp3
pyroptosis
bioactive compounds
Online Access:https://www.dovepress.com/nlrp3-inflammasome-targeting-offers-a-novel-therapeutic-paradigm-for-s-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/nlrp3-inflammasome-targeting-offers-a-novel-therapeutic-paradigm-for-s-peer-reviewed-fulltext-article-DDDT

Similar Items